Komal K. Javarappa

Helsinki, 00290, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Navigating AI and machine learning in cancer research: an end-to-end translational framework.

Navigating AI and machine learning in cancer research: an end-to-end translational framework.

Journal: Journal of translational medicine

Published: April 07, 2026

Predictors of response and rational combinations for the novel MCL-1 inhibitor MIK665 in acute myeloid leukemia.

Predictors of response and rational combinations for the novel MCL-1 inhibitor MIK665 in acute myeloid leukemia.

Journal: Molecular oncology

Published: February 06, 2025

Protocol for assessing and visualizing cell microaggregate formation in whole blood by imaging flow cytometry.

Protocol for assessing and visualizing cell microaggregate formation in whole blood by imaging flow cytometry.

Journal: STAR protocols

Published: May 21, 2024

Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy.

Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy.

Journal: Cancers

Published: March 28, 2023

Megakaryopoiesis impairment through acute innate immune signaling activation by azacitidine.

Megakaryopoiesis impairment through acute innate immune signaling activation by azacitidine.

Journal: The Journal of experimental medicine

Published: November 01, 2021

Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia.

Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia.

Journal: Blood

Published: February 01, 2021

Patient-tailored design for selective co-inhibition of leukemic cell subpopulations.

Patient-tailored design for selective co-inhibition of leukemic cell subpopulations.

Journal: Science advances

Published: August 20, 2020

Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets.

Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets.

Journal: Leukemia

Published: July 27, 2020

KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia.

KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia.

Journal: Leukemia

Published: April 03, 2020

Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia.

Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia.

Journal: Leukemia

Published: June 28, 2018

A Multiplexed Screening Assay to Evaluate Chemotherapy-Induced Myelosuppression Using Healthy Peripheral Blood and Bone Marrow.

A Multiplexed Screening Assay to Evaluate Chemotherapy-Induced Myelosuppression Using Healthy Peripheral Blood and Bone Marrow.

Journal: SLAS discovery : advancing life sciences R & D

Published: June 06, 2018

Bioactivity of Diterpens from the Ethyl Acetate Extract of Kingiodendron pinnatum Rox. Hams.

Bioactivity of Diterpens from the Ethyl Acetate Extract of Kingiodendron pinnatum Rox. Hams.

Journal: Pharmacognosy research

Published: October 04, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026